Skip to main content
See every side of every news story
Published • loading... • Updated

AstraZeneca partners with Oracle for AI-driven clinical trials

The non-binding agreement will test AI tools to find eligible patients earlier and speed evidence generation across trial and care workflows.

  • On Tuesday, October 20, 2026, AstraZeneca announced a collaboration with Oracle to use artificial intelligence and real-world data to accelerate clinical research and improve patient recruitment for trials.
  • Patient recruitment remains a primary challenge in clinical research, as delayed enrollment extends development timelines and increases costs, prompting AstraZeneca to address past trial design failures.
  • The first project will support hypertension research in Abu Dhabi through a partnership with healthcare firm M42. Chief Executive Officer Pascal Soriot said the collaboration brings "leaders in healthcare and AI together at a global scale."
  • Combining AstraZeneca's drug development expertise with Oracle's cloud and analytics capabilities, the partnership aims to help clinicians identify eligible patients sooner. Seema Verma, executive vice president of Oracle Health and Life Sciences, said progress depends on "shortening the distance between scientific insight and the decisions clinicians make every day."
  • AstraZeneca intends to expand its medicine portfolio, targeting over $80 billion in annual revenue by 2030. Chief Digital, Data and AI Officer Anne-Claire Gerbaldi noted the technology aims to address care gaps where patients face long diagnostic journeys.
Insights by Ground AI

39 Articles

Lean Right

Oracle is pursuing a plan with AstraZeneca to leverage artificial intelligence (AI) and real-world data (RWD) to identify patients suitable for clinical trials and connect research outcomes to clinical practice. Oracle announced on the 21st that it had signed a non-binding agreement with AstraZeneca containing these details. The two companies are exploring the potential of AI and the latest applications, focusing on reducing the time and burden …

ReutersReuters
+4 Reposted by 4 other sources
Center

AstraZeneca partners with Oracle for AI-driven clinical trials

AstraZeneca said on Tuesday that it is working with Oracle to use AI ​and real-world data to identify eligible ‌patients for clinical trials and monitor safety signals, among other measures, as the drugmaker looks to ​improve clinical research.

·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Lincoln Journal Star broke the news in Cherokee County, United States on Tuesday, October 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal